Orforglipron significantly reduced body weight by 7.8% (6mg), 9.3% (12mg) and 12.4% (36mg) compared with 0.9% in the placebo arm at week 72. Topline data were announced from a phase 3 trial evaluating ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Adults with obesity and type 2 diabetes had a mean 14 kg ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Tirzepatide lowered HbA1c by 0.45 percentage points at 3 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results